RVL Pharmaceuticals plc (RVLP) Tops Q2 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to RVL Pharmaceuticals plc (RVLP) Tops Q2 EPS by 10c

RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commercial Update

August 11, 2022 6:50 AM EDT

-- Second quarter 2022 UPNEEQ® net product sales of $8.4 million; 42% above first quarter --

-- Opportunity for cash runway to extend through 2023 following recently announced financings --

-- Expanded Board of Directors with the appointment of Alisa Lask, Aesthetic industry veteran with pharmaceutical experience in both sales and marketing --

-- Continued sequential expansion among key UPNEEQ demographics, including pharmacy-paid prescribers and medical aesthetics practices --

BRIDGEWATER, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq:... More